NO20070486L - 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat - Google Patents
1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartratInfo
- Publication number
- NO20070486L NO20070486L NO20070486A NO20070486A NO20070486L NO 20070486 L NO20070486 L NO 20070486L NO 20070486 A NO20070486 A NO 20070486A NO 20070486 A NO20070486 A NO 20070486A NO 20070486 L NO20070486 L NO 20070486L
- Authority
- NO
- Norway
- Prior art keywords
- phenylglycinyl
- methylpiperidin
- indole
- piperazine
- carbonyl
- Prior art date
Links
- FEWJPZIEWOKRBE-LWMBPPNESA-L D-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O FEWJPZIEWOKRBE-LWMBPPNESA-L 0.000 title 1
- VYNKVNDKAOGAAQ-RUZDIDTESA-N n-[(1r)-2-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1h-indole-6-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)[C@H](NC(=O)C=2C=C3NC=CC3=CC=2)C=2C=CC=CC=2)CC1 VYNKVNDKAOGAAQ-RUZDIDTESA-N 0.000 title 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58359904P | 2004-06-30 | 2004-06-30 | |
| PCT/US2005/020490 WO2006011955A1 (en) | 2004-06-30 | 2005-06-13 | 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20070486L true NO20070486L (no) | 2007-01-25 |
Family
ID=35276192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20070486A NO20070486L (no) | 2004-06-30 | 2007-01-25 | 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070249623A1 (https=) |
| EP (1) | EP1763521A1 (https=) |
| JP (1) | JP2008505075A (https=) |
| CN (1) | CN1984903A (https=) |
| AR (1) | AR049659A1 (https=) |
| AU (1) | AU2005267579A1 (https=) |
| BR (1) | BRPI0512245A (https=) |
| CA (1) | CA2570634A1 (https=) |
| EA (1) | EA010307B1 (https=) |
| EC (1) | ECSP067105A (https=) |
| IL (1) | IL179903A0 (https=) |
| MA (1) | MA28842B1 (https=) |
| MX (1) | MXPA06015112A (https=) |
| NO (1) | NO20070486L (https=) |
| PE (1) | PE20060480A1 (https=) |
| SV (1) | SV2006002156A (https=) |
| TW (1) | TW200603806A (https=) |
| WO (1) | WO2006011955A1 (https=) |
| ZA (1) | ZA200610091B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0616574D0 (en) * | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
| CN107365304A (zh) * | 2017-08-01 | 2017-11-21 | 齐宜涛 | 一种治疗心血管疾病的化合物及制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
| EP1163217B1 (en) * | 1999-03-15 | 2005-09-21 | Novo Nordisk A/S | New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| DE60022508T2 (de) * | 1999-06-14 | 2006-06-08 | Eli Lilly And Co., Indianapolis | Inhibitoren von serin proteasen |
| US6448293B1 (en) * | 2000-03-31 | 2002-09-10 | Pfizer Inc. | Diphenyl ether compounds useful in therapy |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0019228D0 (en) * | 2000-08-04 | 2000-09-27 | Smithkline Beecham Plc | Novel pharmaceutical |
| CA2447405C (en) * | 2001-05-14 | 2006-10-17 | Pfizer Products Inc. | Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| TWI257389B (en) * | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
-
2005
- 2005-06-13 BR BRPI0512245-7A patent/BRPI0512245A/pt not_active IP Right Cessation
- 2005-06-13 CN CNA2005800214090A patent/CN1984903A/zh active Pending
- 2005-06-13 EP EP05760368A patent/EP1763521A1/en not_active Withdrawn
- 2005-06-13 WO PCT/US2005/020490 patent/WO2006011955A1/en not_active Ceased
- 2005-06-13 CA CA002570634A patent/CA2570634A1/en not_active Abandoned
- 2005-06-13 JP JP2007519246A patent/JP2008505075A/ja active Pending
- 2005-06-13 EA EA200700186A patent/EA010307B1/ru not_active IP Right Cessation
- 2005-06-13 AU AU2005267579A patent/AU2005267579A1/en not_active Abandoned
- 2005-06-13 US US11/570,686 patent/US20070249623A1/en not_active Abandoned
- 2005-06-13 MX MXPA06015112A patent/MXPA06015112A/es not_active Application Discontinuation
- 2005-06-17 TW TW094120115A patent/TW200603806A/zh unknown
- 2005-06-27 PE PE2005000741A patent/PE20060480A1/es not_active Application Discontinuation
- 2005-06-29 AR ARP050102705A patent/AR049659A1/es unknown
- 2005-06-29 SV SV2005002156A patent/SV2006002156A/es not_active Application Discontinuation
-
2006
- 2006-12-01 ZA ZA200610091A patent/ZA200610091B/en unknown
- 2006-12-07 IL IL179903A patent/IL179903A0/en unknown
- 2006-12-20 EC EC2006007105A patent/ECSP067105A/es unknown
-
2007
- 2007-01-25 NO NO20070486A patent/NO20070486L/no not_active Application Discontinuation
- 2007-01-29 MA MA29641A patent/MA28842B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1984903A (zh) | 2007-06-20 |
| EA010307B1 (ru) | 2008-08-29 |
| SV2006002156A (es) | 2006-02-15 |
| WO2006011955A1 (en) | 2006-02-02 |
| JP2008505075A (ja) | 2008-02-21 |
| AU2005267579A1 (en) | 2006-02-02 |
| IL179903A0 (en) | 2007-05-15 |
| MA28842B1 (fr) | 2007-09-03 |
| EA200700186A1 (ru) | 2007-06-29 |
| PE20060480A1 (es) | 2006-07-13 |
| TW200603806A (en) | 2006-02-01 |
| ZA200610091B (en) | 2008-02-27 |
| US20070249623A1 (en) | 2007-10-25 |
| MXPA06015112A (es) | 2007-02-08 |
| CA2570634A1 (en) | 2006-02-02 |
| BRPI0512245A (pt) | 2008-02-19 |
| ECSP067105A (es) | 2007-01-26 |
| AR049659A1 (es) | 2006-08-23 |
| EP1763521A1 (en) | 2007-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP53708A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| HRP20090265T1 (hr) | Derivati 1-benzoil-piperazina kao inhibitori apsorpcije glicina za liječenje psihoza | |
| CY1119076T1 (el) | Αλατα πιπεραζινης ως ανταγωνιστες των d3/d2 | |
| NO20061562L (no) | Anvendelse av 1- [4-(5-cyanindol-3yl)butyl ] -4-(2-karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptable salter | |
| CR9783A (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
| DE602004011076D1 (de) | Piperazin mit or-substituierter phenylgruppe und deren verwendung als glyt1-inhibitoren | |
| MY121136A (en) | Novel heterocyclic sulfonamides. | |
| EP2602259A3 (en) | Salt of proline derivative, solvate thereof, and production method thereof | |
| UA74372C2 (uk) | Інгібітори серинових протеаз, фармацевтична композиція на їх основі | |
| PE20141681A1 (es) | Inhibidores de btk | |
| NO20060768L (no) | 1-(2-amino-benzol)-piperazinderivater som glycinopptaks-inhibitorer for behandling av psykoser | |
| NO20005264D0 (no) | Heterocyklisk substituerte amider, deres fremstilling og anvendelse | |
| NO20070486L (no) | 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat | |
| CO5700748A2 (es) | Derivados de 4-(2-fenilsulfanil-fenil)-piperidina como inhibidores de recaptacion de serotonina | |
| TW200607805A (en) | Novel pyridazinone derivatives, methods for producing them and their use as pharmaceuticals | |
| MY137876A (en) | Pharmaceutical compound | |
| DE60301569T2 (de) | Bestimmte 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazin verbindungen als inhibitoren der serin protease factor xa | |
| MXPA03010205A (es) | Derivados de acido oxalico. | |
| ATE468855T1 (de) | Kombination von stickstoff-senf analogen und imatinib für die behandlung von chronischer lymphatischer leukämie | |
| DE602004022540D1 (de) | Verwendung von tyrosin-kinase-hemmern zur behandlung von diabetes | |
| NO20031698D0 (no) | Krystallformer av 1-(6-klor-5-(trifluormetyl)-2- pyridinyl)piperazin-hydroklorid | |
| TH64469A (th) | สารประกอบทางเภสัชกรรม | |
| DE60305460D1 (de) | Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen | |
| SE0202673D0 (sv) | Chemical compounds | |
| AR107852A2 (es) | Derivados de pirrol como inhibidor de secreción ácida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |